Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno‐inflammatory diseases

Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno‐inflammatory diseases

Abstract The objective of this population pharmacokinetic (PK) analysis was to characterize the concentration–time profile of brepocitinib plasma concentration after single‐ and multiple‐oral administration in healthy volunteers (HVs) and patients with immuno‐inflammatory diseases. Blood samples fro...

Full description

Bibliographic Details
Main Authors: Farzaneh Maleki, Elias Clark, Christopher Banfield, Wonkyung Byon, Timothy Nicholas
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:CPT: Pharmacometrics & Systems Pharmacology
Online Access:https://doi.org/10.1002/psp4.13100

Internet

https://doi.org/10.1002/psp4.13100

Similar Items